Cargando…
Editorial Commentary: Galactomannan Testing During Mold-Active Prophylaxis
Autor principal: | Cornely, Oliver A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4243699/ https://www.ncbi.nlm.nih.gov/pubmed/25165089 http://dx.doi.org/10.1093/cid/ciu677 |
Ejemplares similares
-
Cost-Effectiveness of Serum Galactomannan Surveillance during Mould-Active Antifungal Prophylaxis
por: Khoo, Ai Leng, et al.
Publicado: (2021) -
All You Need to Know and More about the Diagnosis and Management of Rare Mold Infections
por: Hoenigl, Martin, et al.
Publicado: (2021) -
Editorial Commentary
por: Mosli, Hisham A.
Publicado: (2011) -
Pharmacodynamics of Isavuconazole for Invasive Mold Disease: Role of Galactomannan for Real-Time Monitoring of Therapeutic Response
por: Kovanda, Laura L., et al.
Publicado: (2017) -
Editorial Commentary: Microbiologic Testing in Post–Solid Organ Transplant Diarrhea
por: Polage, Christopher R.
Publicado: (2015)